Health Care Plans Technical Data -- CVS Health, UnitedHealth Group, Anthem, Centene, and Humana

NEW YORK, September 28, 2015 /PRNewswire/ --

Equity Research Institute has initiated coverage on the following equities: CVS Health Corporation (NYSE: CVS), UnitedHealth Group Inc. (NYSE: UNH), Anthem Inc. (NYSE: ANTM), Centene Corporation (NYSE: CNC), and Humana Inc. (NYSE: HUM). Free research report on CVS Health can be accessed at https://www.erionline.net/CVS.pdf On Friday, September 25, 2015, the NASDAQ Composite ended at 4,686.50, down 1.01%, the Dow Jones Industrial Average advanced 0.70%, to finish the day at 16,314.67, and the S&P 500 closed at 1,931.34, down 0.05%. The losses were broad based as six out of nine sectors ended the session in negative. Register for your complimentary reports at the links given below.  

CVS Health Corp.'s stock edged 0.56% lower, to close the day at $98.61. The stock recorded a trading volume of 4.94 million shares, above its three months average volume of 4.78 million shares. Over the last one month and over the past three months, CVS Health Corp.'s shares have fallen by 4.14% and 6.54%, respectively. However, the stock has advanced 3.43% since the start of this year. The company's shares are trading 3.25% below their 200-day moving average. Additionally, CVS Health Corp. traded at a PE ratio of 23.70 and has a Relative Strength Index (RSI) of 37.33. Sign up and read the free notes on CVS at:

https://www.erionline.net/CVS.pdf

On Friday, shares in UnitedHealth Group Inc. recorded a trading volume of 8.06 million shares, higher than their three months average volume of 4.37 million shares. The stock ended the day 3.90% lower at $116.37. Shares of the company traded at a PE ratio of 18.71. Although, UnitedHealth Group Inc.'s stock has lost 5.17% in the previous three months, it has advanced 3.01% in the last one month and 16.49% on YTD basis. The company is trading above its 200-day moving average by 1.78%. Furthermore, shares of UnitedHealth Group Inc. have an RSI of 44.14. The complimentary notes on UNH can be downloaded in PDF format at:

https://www.erionline.net/UNH.pdf

Anthem Inc.'s stock declined 3.50%, to close Friday's session at $141.91. The stock recorded a trading volume of 2.21 million shares, close to its three months average volume of 2.17 million shares. Over the last one month and since the beginning of 2015, Anthem Inc.'s shares have advanced 0.27% and 14.35%, respectively. However, the stock has declined 13.45% in the previous three months. The company is trading 4.55% and 4.11% below its 50-day and 200-day moving averages, respectively. Furthermore, Anthem Inc.'s stock traded at a PE ratio of 13.86 and has an RSI of 41.00. Register for free on Equity Research Institute and access the latest research on ANTM at:

https://www.erionline.net/ANTM.pdf

Centene Corp.'s stock finished Friday's session 4.70% lower at $58.61. A total of 1.82 million shares were traded, which was close to its three months average volume of 1.86 million shares. Over the last one month and the previous three months, Centene Corp.'s shares have lost 6.75% and 27.07%, respectively. However, the stock has gained 12.87% since the beginning of 2015. The company's shares are trading below their 50-day and 200-day moving averages by 12.09% and 10.44%, respectively. Centene Corp.'s stock traded at a PE ratio of 21.08 and has an RSI of 33.97. The complete research on CNC is available for free at:

https://www.erionline.net/CNC.pdf

On Friday, shares in Humana Inc. ended the session 2.59% lower at $181.15. The stock reported a trading volume of 1.31 million shares, below its three months average volume of 1.78 million shares. Shares of the company traded at a PE ratio of 21.39. Although, Humana Inc.'s shares have lost 7.34% in the previous three months, it has advanced 0.23% in the last one month and 26.51% on YTD basis. The company is trading 4.27% above its 200-day moving average. Moreover, shares of Humana Inc. have an RSI of 39.49. Free in-depth research on HUM is available at:

https://www.erionline.net/HUM.pdf

--

About Equity Research Institute: 

Equity Research Institute ("ERI") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ERI has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ERI has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:  

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY 

ERI, the Author, the Reviewer and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ERI nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.erionline.net.

RESTRICTIONS 

ERI is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE www.erionline.net

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED